AR053100A1 - Procedimiento para preparar derivados condensados de piperazin-2-ona e intermediario - Google Patents

Procedimiento para preparar derivados condensados de piperazin-2-ona e intermediario

Info

Publication number
AR053100A1
AR053100A1 ARP050105040A ARP050105040A AR053100A1 AR 053100 A1 AR053100 A1 AR 053100A1 AR P050105040 A ARP050105040 A AR P050105040A AR P050105040 A ARP050105040 A AR P050105040A AR 053100 A1 AR053100 A1 AR 053100A1
Authority
AR
Argentina
Prior art keywords
alkyl
optionally substituted
hydrogen
mean
group
Prior art date
Application number
ARP050105040A
Other languages
English (en)
Inventor
Adil Duran
Guenter Linz
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35923724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR053100(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AR053100A1 publication Critical patent/AR053100A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Reivindicacion 1: Procedimiento para preparar compuestos de formula general (1), en la cual R1 significa un radical seleccionado del grupo compuesto por cloro, fluoro, bromo, metansulfonilo, etansulfonilo, trifluorometansulfonilo, para- toluensulfonilo, CH3S(=O)- y fenilS(=O)-, R2 significa hidrogeno o alquilo C1-C3, R3 significa hidrogeno o un radical seleccionado del grupo compuesto por alquilo C1-C12, alquenilo C2-C12, alquinilo C2-C12 y arilo C6-C14, eventualmente sustituidos, o bien un radical seleccionado del grupo compuesto por cicloalquilo C3-C12, cicloalquenilo C7-C12, policicloalquilo C7-C12, policicloalquenilo C7-C12, espirocicloalquilo C5-C12, eventualmente sustituidos y/o puenteados, y heterociclo-alquilo C3-C12 saturado o insaturado, que contiene 1 a 2 heteroátomos, eventualmente sustituido y/o puenteado, R4, R5, iguales o diferentes, significan hidrogeno o alquilo C1-C6 eventualmente sustituido, o bien R4 y R5 significan juntos un puente de alquilo de 2 a 5 miembros, que puede contener 1 a 2 heteroátomos, o bien R4 y R3 o R5 y R3 significan juntos un puente de alquilo C3-C4 saturado o insaturado, que eventualmente puede contener 1 heteroátomo, y A1 y A2, iguales o diferentes, significan -CH= o -N=, caracterizado porque un compuesto de formula (2), en la cual R1 hasta R5, A1 y A2 tienen el significado indicado en la reivindicacion 1 y R6 significa alquilo C1-C4, a) es hidrogenado con hidrogeno en presencia de un catalizador de hidrogenacion, y b) se le anade un compuesto de cobre, de hierro o de vanadio, pudiendo efectuarse los pasos a) y B) simultánea o sucesivamente. Reivindicacion 14: Compuesto de formula (3), en donde R1 hasta R5 tienen el significado indicado en la reivindicacion 1.
ARP050105040A 2004-12-02 2005-12-02 Procedimiento para preparar derivados condensados de piperazin-2-ona e intermediario AR053100A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004058337A DE102004058337A1 (de) 2004-12-02 2004-12-02 Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten

Publications (1)

Publication Number Publication Date
AR053100A1 true AR053100A1 (es) 2007-04-25

Family

ID=35923724

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105040A AR053100A1 (es) 2004-12-02 2005-12-02 Procedimiento para preparar derivados condensados de piperazin-2-ona e intermediario

Country Status (35)

Country Link
US (9) US7238807B2 (es)
EP (2) EP1819706B1 (es)
JP (1) JP5164574B2 (es)
KR (2) KR101395591B1 (es)
CN (3) CN101065381B (es)
AR (1) AR053100A1 (es)
AU (1) AU2005311308B2 (es)
BR (1) BRPI0518601A2 (es)
CA (1) CA2588857C (es)
CL (1) CL2013002895A1 (es)
CY (1) CY1113625T1 (es)
DE (1) DE102004058337A1 (es)
DK (2) DK1819706T3 (es)
EA (1) EA012624B1 (es)
ES (2) ES2548680T3 (es)
HK (3) HK1113489A1 (es)
HR (1) HRP20120980T1 (es)
HU (1) HUE027689T2 (es)
IL (1) IL183568A (es)
ME (1) ME01470B (es)
MX (1) MX2007006549A (es)
MY (1) MY147459A (es)
NO (1) NO20072283L (es)
NZ (1) NZ556182A (es)
PE (2) PE20090488A1 (es)
PL (2) PL1819706T3 (es)
PT (1) PT1819706E (es)
RS (1) RS52533B (es)
SG (2) SG158848A1 (es)
SI (1) SI1819706T1 (es)
TW (1) TWI362391B (es)
UA (1) UA89390C2 (es)
UY (1) UY29233A1 (es)
WO (1) WO2006058876A1 (es)
ZA (1) ZA200703368B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861422B2 (en) * 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) * 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7759485B2 (en) * 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US7728134B2 (en) * 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
DE602007008837D1 (de) 2006-02-14 2010-10-14 Vertex Pharma Als protein-kinase-inhibitoren nutzbare dyhydrodiazepine
JP4958461B2 (ja) * 2006-03-30 2012-06-20 富士フイルム株式会社 近赤外吸収色素含有硬化性組成物
CN101652365A (zh) 2007-02-01 2010-02-17 阿斯利康(瑞典)有限公司 作为hsp90抑制剂的5,6,7,8-四氢蝶啶衍生物
WO2009019205A1 (en) * 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
EP2100894A1 (en) 2008-03-12 2009-09-16 4Sc Ag Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors
CN102020643A (zh) 2009-09-22 2011-04-20 上海恒瑞医药有限公司 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
CN103492391A (zh) 2009-09-25 2014-01-01 沃泰克斯药物股份有限公司 用于制备用作蛋白激酶抑制剂的嘧啶衍生物的方法
CA2773742C (en) 2009-09-25 2017-12-05 Vertex Pharmaceuticals Incorporated Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
JP5931933B2 (ja) 2011-02-25 2016-06-08 武田薬品工業株式会社 N−置換オキサジノプテリジンおよびオキサジノプテリジノン
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
UY34893A (es) 2012-07-10 2014-02-28 Takeda Pharmaceutical Derivados de azaindol
WO2015011236A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
WO2015106012A1 (en) 2014-01-09 2015-07-16 Takeda Pharmaceutical Company Limited Azaindole derivatives
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032639A (en) * 1976-03-22 1977-06-28 American Home Products Corporation 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension
US4182872A (en) * 1976-03-22 1980-01-08 American Home Products Corporation 4-(Lower)alkyl-1-(o-nitrophenyl)piperazine-2-carboxylic acid chemical intermediates
NL8303657A (nl) 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
ES2058527T3 (es) 1988-06-16 1994-11-01 Smith Kline French Lab Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
FR2645152B1 (fr) 1989-03-30 1991-05-31 Lipha 3h-pteridinones-4, procedes de preparation et medicaments les contenant
US5043270A (en) 1989-03-31 1991-08-27 The Board Of Trustees Of The Leland Stanford Junior University Intronic overexpression vectors
CA2029651C (en) 1989-11-17 2000-06-06 David D. Davey Tricyclic pteridinones and a process for their preparation
US5198547A (en) 1992-03-16 1993-03-30 South Alabama Medical Science Foundation, Usa Process for N5-formylating tetrahydropteridines
TW274550B (es) * 1992-09-26 1996-04-21 Hoechst Ag
EP1195372A1 (en) 1994-04-18 2002-04-10 Mitsubishi Pharma Corporation N-heterocyclic substituted benzamide derivatives with antihypertensive activity
CO4410191A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
DK0825979T3 (da) * 1995-05-19 2001-05-07 Novartis Ag Fremgangsmåde til fremstilling af aromatiske nitroforbindelser
US5698556A (en) * 1995-06-07 1997-12-16 Chan; Carcy L. Methotrexate analogs and methods of using same
BR9711541A (pt) 1996-09-23 1999-08-24 Lilly Co Eli Dihidrato d de olanzapina
CA2340180A1 (en) * 1998-08-11 2000-02-24 Pfizer Products Inc. 1-aryl,-3-arylmethyl-1,8-naphthyridn-2(1h)-ones
MXPA02001108A (es) 1999-09-15 2002-08-20 Warner Lambert Co Pieridinonas como inhibidores de la cinasa.
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
AP2002002643A0 (en) 2000-03-06 2002-12-31 Warner Lambert Co 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
DE10018783A1 (de) 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
US20020183292A1 (en) * 2000-10-31 2002-12-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and corticosteroids
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
US6756374B2 (en) 2001-01-22 2004-06-29 Hoffmann-La Roche Inc. Diaminothiazoles having antiproliferative activity
WO2002076954A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
WO2002076985A1 (en) 2001-03-23 2002-10-03 Smithkline Beecham Corporation Compounds useful as kinase inhibitors for the treatment of hyperproliferative diseases
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US6806272B2 (en) * 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
CN1551881A (zh) * 2001-09-04 2004-12-01 ���ָ��Ӣ��ķ�������Ϲ�˾ 新颖二氢喋啶酮,其制备方法及作为药物组合物的用途
BRPI0117198B1 (pt) * 2001-12-14 2018-03-13 Merck Serono S.A. Usos de composição compreendendo um inibidor seletivo de uma isoforma 4 de fosfodiesterase
JP2005538048A (ja) 2002-05-03 2005-12-15 シエーリング アクチエンゲゼルシャフト チアゾリジノン類、それらの生成及び医薬剤としての使用
US20060074119A1 (en) 2002-08-08 2006-04-06 Andrews Clarence W Iii Thiophene compounds
US6862422B2 (en) * 2003-02-12 2005-03-01 Kabushiki Kaisha Toshiba Image forming apparatus and image forming method having pressing members for pressing a belt-like member
EA008778B1 (ru) 2003-02-26 2007-08-31 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг Дигидроптеридиноны, способ их получения и их применение в качестве лекарственных средств
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20040180898A1 (en) * 2003-03-03 2004-09-16 Bang-Chi Chen Processes for preparing imidazoquinoxalinones, heterocyclic-substituted imidazopyrazinones, imidazoquinoxalines and heterocyclic-substituted imidazopyrazines
PL1605971T3 (pl) 2003-03-26 2010-10-29 Wyeth Llc Kompozycja immunogenna i sposoby
AU2004231342A1 (en) 2003-04-14 2004-11-04 Vectura Ltd Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
JP2007517828A (ja) 2004-01-17 2007-07-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 気道の疾患を治療するための置換プテリジンの使用
DE102004029784A1 (de) * 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
DE102004034623A1 (de) * 2004-07-16 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060035903A1 (en) * 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
US20060074088A1 (en) * 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
EP1632493A1 (de) * 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) * 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
JP2008510770A (ja) 2004-08-26 2008-04-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Plk阻害剤としての新規プテリジノン
EP1784406A1 (de) * 2004-08-27 2007-05-16 Boehringer Ingelheim International GmbH Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE102004058337A1 (de) * 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
CA2617589A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Dihydropteridinones in the treatment of respiratory diseases
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
JP2009529038A (ja) 2006-03-07 2009-08-13 アストラゼネカ・アクチエボラーグ ピペリジン誘導体、それらの製造法、治療剤としてのそれらの使用およびそれらを含む医薬組成物
WO2009019205A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative

Also Published As

Publication number Publication date
HK1158200A1 (en) 2012-07-13
PL1819706T3 (pl) 2013-03-29
EA200701164A1 (ru) 2007-12-28
CN102070637B (zh) 2012-09-26
JP2008521861A (ja) 2008-06-26
HK1158199A1 (en) 2012-07-13
HUE027689T2 (hu) 2021-12-28
US20060122393A1 (en) 2006-06-08
SG141461A1 (en) 2008-04-28
CA2588857A1 (en) 2006-06-08
ES2395829T3 (es) 2013-02-15
US7238807B2 (en) 2007-07-03
EP2436685A1 (de) 2012-04-04
ES2548680T3 (es) 2015-10-20
EP1819706B1 (de) 2012-09-19
US20070213531A1 (en) 2007-09-13
WO2006058876A1 (de) 2006-06-08
RS52533B (en) 2013-04-30
MX2007006549A (es) 2007-06-18
PT1819706E (pt) 2012-12-06
ZA200703368B (en) 2008-09-25
UA89390C2 (ru) 2010-01-25
US20070208027A1 (en) 2007-09-06
DK1819706T3 (da) 2013-01-02
TW200628471A (en) 2006-08-16
DE102004058337A1 (de) 2006-06-14
AU2005311308A1 (en) 2006-06-08
PE20090488A1 (es) 2009-05-27
UY29233A1 (es) 2006-07-31
MY147459A (en) 2012-12-14
USRE43115E1 (en) 2012-01-17
US20070219369A1 (en) 2007-09-20
US7626019B2 (en) 2009-12-01
CN101065381B (zh) 2011-03-30
CN102070637A (zh) 2011-05-25
CN101065381A (zh) 2007-10-31
ME01470B (me) 2014-04-20
IL183568A0 (en) 2007-09-20
PL2436685T3 (pl) 2015-11-30
CA2588857C (en) 2013-10-08
HRP20120980T1 (hr) 2012-12-31
CY1113625T1 (el) 2016-06-22
KR20070092252A (ko) 2007-09-12
US20070213530A1 (en) 2007-09-13
EA012624B1 (ru) 2009-10-30
DK2436685T3 (en) 2015-09-14
KR101395591B1 (ko) 2014-05-16
AU2005311308B2 (en) 2012-04-12
JP5164574B2 (ja) 2013-03-21
EP1819706A1 (de) 2007-08-22
NO20072283L (no) 2007-06-28
PE20061061A1 (es) 2006-11-10
TWI362391B (en) 2012-04-21
KR20120136414A (ko) 2012-12-18
HK1113489A1 (en) 2008-10-03
SG158848A1 (en) 2010-02-26
US20070213529A1 (en) 2007-09-13
IL183568A (en) 2015-02-26
SI1819706T1 (sl) 2013-01-31
CL2013002895A1 (es) 2014-03-14
CN102093361A (zh) 2011-06-15
CN102093361B (zh) 2014-05-07
BRPI0518601A2 (pt) 2008-11-25
EP2436685B1 (de) 2015-07-01
KR101362131B1 (ko) 2014-02-19
US20070213534A1 (en) 2007-09-13
NZ556182A (en) 2009-08-28
US20070213528A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
AR053100A1 (es) Procedimiento para preparar derivados condensados de piperazin-2-ona e intermediario
MA27622A1 (fr) Insecticides a base de cyano-anthranilamide
AR057987A1 (es) Compuestos agonistas de cb1 (receptor cannabinoide)
UA115661C2 (uk) Сполуки тетразолінону і їх застосування як пестицидів
CO6321130A2 (es) Piridinas carboxamidas como inhibidores de la 11 beta-hsd1
AR075084A1 (es) Metodo de preparacion de quinolinil -oxidifenil - ciclopropanodicarboxamidas e intermediarios correspondientes
CO6231035A2 (es) Novedoso compuesto heteromonociclico que tiene propiedades superiores como agente farmaceutico
CO6160266A2 (es) Derivado de oxopirazina y herbicida
EA200601830A1 (ru) Ортозамещённые арильные или гетероарильные амидные соединения
AR033295A1 (es) Compuestos biciclicos de pirimidina, proceso para su obtencion, uso de los mismos para la preparacion de una composicion farmaceutica y dicha composicion farmaceutica
AR064355A1 (es) Herbicidas derivados de isoxazol
AR035884A1 (es) Derivado de amida aromatico sustituido, derivado de amina aromatico sustituido con un grupo fluoroalquilo util como intermediario para obtener el mismo, insecticida para agrohorticultura que lo contiene y metodo para usar este ultimo
PE20180030A1 (es) Compuestos biciclicos de sulfonamida cetona
UY31986A (es) Derivados n- sustituídos de la 2-metil-propionamida;{1-[5-sustiuido-4-sustituido-tiazol-2-il-carbamoil]-1-metil-etil} amidas de ácidos carboxílicos sustituidos, derivados farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
AR056103A1 (es) Compuestos de(piran-piperidinil)benzimidazol, composiciones farmaceuticas que los comprenden, proceso de preparacion y usos en el tratamiento de afecciones mediadas por agonistas del receptor muscarinico m1
CA2871190C (en) Substituted diarylamines and use of same as antioxidants
ECSP088805A (es) 2-(piridin-2-il)-pirimidinas como fungicidas
CR10057A (es) Compuesto heterocíclico fusionado
UY30009A1 (es) Compuestos benzoilpirazol y herbicidas que los contienen
DK1787168T3 (da) Ikke-vandige mikroelektroniske rengøringssammensætninger indeholdende fruktose
CO5650235A2 (es) Derivados de imidazol
PE20090593A1 (es) Compuestos heterociclos como antagonistas del receptor de bradiquinina b1
AR111272A1 (es) Derivados pirazol[1,5-a]pirimidina sustituidos con arilo farmacológicamente activos
PE20040682A1 (es) Derivados de ciclobutano como antagonistas de nk1
CO5550437A2 (es) Compuestos quimicos

Legal Events

Date Code Title Description
FB Suspension of granting procedure